Last reviewed · How we verify

NCT03840551: BIOS-ACL

Definition of Biomechanical Indices Measurable During Sport Movements for the Prevention of Primary and Secondary ACL Injury

Completed NA Last updated 10 February 2021
What this trial tests

NA trial testing Biomechanical analysis with inertial sensors (XSENS) and motion capture (BTS) in Sport Injury in 34 participants. Completed in 1 October 2020.

Timeline
15 December 2018
Primary endpoint
10 August 2019
1 October 2020

Quick facts

Lead sponsorIstituto Ortopedico Rizzoli
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment34
Start date15 December 2018
Primary completion10 August 2019
Estimated completion1 October 2020
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 18 to 50, any sex, with Sport Injury or Anterior Cruciate Ligament Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to define a set of quantitative parameters related to articular biomechanics, which will be evaluated during some specific motor tasks. The goal is the prevention of primary and secondary anterior cruciate ligament injury in athletes. Specifically, the validation of a new comparative methodology of biomechanics analysis will be performed, based on inertial sensors and musculoskeletal models. This way, brief but exhaustive description of functional characteristics of athletes could be created and easily used in ambulatory environment.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Rehabilitation and Return to Sport Assessment after Anterior Cruciate Ligament Injury: Quantifying Joint Kinematics during Complex High-Speed Tasks through Wearable Sensors.
    Di Paolo S, Lopomo NF, Della Villa F, Paolini G, et al · · 2021 · cited 40× · PMID 33810610 · DOI 10.3390/s21072331
  2. A 2D video-analysis scoring system of 90° change of direction technique identifies football players with high knee abduction moment.
    Della Villa F, Di Paolo S, Santagati D, Della Croce E, et al · · 2022 · cited 23× · PMID 33912979 · DOI 10.1007/s00167-021-06571-2
  3. A 2D qualitative movement assessment of a deceleration task detects football players with high knee joint loading.
    Di Paolo S, Zaffagnini S, Tosarelli F, Aggio F, et al · · 2021 · cited 18× · PMID 34480582 · DOI 10.1007/s00167-021-06709-2
  4. Two-Dimensional and Three-Dimensional Biomechanical Factors During 90° Change of Direction are Associated to Non-Contact ACL injury in Female Soccer Players.
    Di Paolo S, Grassi A, Tosarelli F, Crepaldi M, et al · · 2023 · cited 12× · PMID 37547837 · DOI 10.26603/001c.84308
  5. Knee Joint Contact Forces during High-Risk Dynamic Tasks: 90° Change of Direction and Deceleration Movements.
    Cassiolas G, Di Paolo S, Marchiori G, Grassi A, et al · · 2023 · cited 10× · PMID 36829673 · DOI 10.3390/bioengineering10020179
  6. Beyond Distance: A Simple Qualitative Assessment of the Single-Leg Hop Test in Return-to-Play Testing.
    Di Paolo S, Zaffagnini S, Tosarelli F, Grassi A, et al · · 2022 · cited 10× · PMID 35081839 · DOI 10.1177/19417381211063450
  7. Development and Validation of an Algorithm for Foot Contact Detection in High-Dynamic Sports Movements Using Inertial Measurement Units.
    Di Paolo S, Mendicino M, Palha de Araújo Dos Santos JM, Nijmeijer E, et al · · 2026 · PMID 41682504 · DOI 10.3390/s26030988

Verify or expand the search:

Other recruiting trials for Sport Injury

Currently open trials in the same condition.

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03840551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing